A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 inAdults with Severe HypertriglyceridemiaProtocol Number: AROAPOC3-2001

Project: Research project

Project Details

Description

A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Severe Hypertriglyceridemia Protocol Number: AROAPOC3-2001
StatusActive
Effective start/end date3/1/213/31/25

Funding

  • ARROWHEAD PHARMACEUTICALS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.